On May 29, 2024, Virgin Galactic Holdings, Inc. received a notice from the New York Stock Exchange (NYSE) indicating that the company's stock had not maintained the required minimum average closing price of $1.00 over a consecutive 30-day trading period. The company, which is listed under the ticker symbol SPCE, has six months to regain compliance with the NYSE's continued listing standards. Virgin Galactic has expressed its intention to address the deficiency by proposing a reverse stock split, subject to stockholder approval at the upcoming annual meeting scheduled for June 12, 2024. The reverse stock split ratio could range from 1-for-2 to 1-for-20, as determined by the company's Board of Directors. Virgin Galactic's common stock will continue to trade on the NYSE during the six-month cure period. The company remains focused on its strategic goals, including the launch of Delta Class spaceships for commercial service in 2026.

On May 29, 2024, Virgin Galactic Holdings, Inc. received a notice from the New York Stock Exchange (NYSE) indicating that the company's stock had not maintained the required minimum average closing price of $1.00 over a consecutive 30-day trading period. The company, which is listed under the ticker symbol SPCE, has six months to regain compliance with the NYSE's continued listing standards. Virgin Galactic has expressed its intention to address the deficiency by proposing a reverse stock split, subject to stockholder approval at the upcoming annual meeting scheduled for June 12, 2024. The reverse stock split ratio could range from 1-for-2 to 1-for-20, as determined by the company's Board of Directors. Virgin Galactic's common stock will continue to trade on the NYSE during the six-month cure period. The company remains focused on its strategic goals, including the launch of Delta Class spaceships for commercial service in 2026.